Common use of Investigatory Meetings Clause in Contracts

Investigatory Meetings. A. An employee required to attend an investigatory meeting shall receive advance notice of such meeting. Such notice shall include: 1. A statement of the reasons for such meeting, including the subject matter and the fact that the meeting could lead to discipline, and 2. A statement of the employee's right to representation. B. All investigatory meetings shall be scheduled to allow an employee a reasonable opportunity to obtain representation. Whenever practicable, such notice shall be given at least three (3) working days prior to the meeting. C. An employee may represent himself or herself or may be represented by OCEA in an investigatory meeting. An employee is not entitled to be represented by privately retained counsel at the meeting, provided, however, an employee eligible for Legal Defense Fund coverage (LDF) under PORAC or any other OCEA-approved LDF provider shall be entitled to be represented by privately retained counsel obtained through that coverage during the investigatory process including, but not limited to, the investigatory meeting.

Investigatory Meetings. ‌ A. An employee required to attend an investigatory meeting shall receive advance notice of such meeting. Such notice shall include: 1. A statement of the reasons for such meeting, including the subject matter and the fact that the meeting could lead to discipline, and 2. A statement of the employee's right to representation. B. All investigatory meetings shall be scheduled to allow an employee a reasonable opportunity to obtain representation. Whenever practicable, such notice shall be given at least three (3) working days prior to the meeting. C. An employee may represent himself or herself or may be represented by OCEA in an investigatory meeting. An employee is not entitled to be represented by privately retained counsel at the meeting, provided, however, an employee eligible for Legal Defense Fund coverage (LDF) under PORAC or any other OCEA-approved LDF provider shall be entitled to be represented by privately retained counsel obtained through that coverage during the investigatory process including, but not limited to, the investigatory meeting.